Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | PDE4A | P27815 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10874600 | 0.94 | ALDH1A1 (0.41) | ALDH1A1ALOX15TSHRLMNASMN1; SMN2 | |
| SCHEMBL20502388 | 0.82 | HRH4 (0.43) | ALDH1A1ALOX15TSHRLMNASMN1; SMN2 | |
| SCHEMBL27573938 | 0.78 | PDE4A (0.32) | LMNASMN1; SMN2PDE4A | |
| SCHEMBL19295104 | 0.78 | PDE4A (0.35) | LMNASMN1; SMN2PDE4A | |
| SCHEMBL28686121 | 0.75 | LMNA (0.33) | LMNAPDE4A | |
| SCHEMBL15720180 | 0.75 | ALDH1A1 (0.42) | ALDH1A1ALOX15TSHRLMNASMN1; SMN2 | |
| SCHEMBL376361 | 0.73 | CYP1A2 (0.31) | CYP1A2 | |
| SCHEMBL14602892 | 0.71 | — | — | |
| SCHEMBL7195373 | 0.71 | ALDH1A1 (0.38) | ALDH1A1ALOX15TSHRLMNASMN1; SMN2 | |
| SCHEMBL1350091 | 0.71 | LMNA (0.30) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260052903-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2026-02-19 | — | — | US | disclosed |
| US-11759528-B2 | Peg linker and ligand drug conjugate | JENKEM TECHNOLOGY CO., LTD. (BEIJING) (CN) | 2023-09-19 | — | — | US | disclosed |
| CN-116390928-A | Organic electroluminescent element, organic EL display device, and organic EL illumination | 三菱化学株式会社 | 2023-07-04 | — | — | CN | disclosed |
| US-20230002428-A1 | Iridium Complex Compound, Iridium-Complex-Compound-Containing Composition, Organic Electroluminescent Element and Method for Producing Same, Organic EL Display Device, and Organic EL Illuminator | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-01-05 | — | — | US | disclosed |
| US-20230002428-A1 | Iridium Complex Compound, Iridium-Complex-Compound-Containing Composition, Organic Electroluminescent Element and Method for Producing Same, Organic EL Display Device, and Organic EL Illuminator | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-01-05 | — | — | US | disclosed |
| EP-4105222-A1 | IRIDIUM COMPLEX COMPOUND, IRIDIUM COMPLEX COMPOUND-CONTAINING COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT AND PRODUCTION METHOD THEREFOR, ORGANIC EL DISPLAY DEVICE, AND ORGANIC EL LIGHTING DEVICE | Mitsubishi Chemical Corporation (JP) | 2022-12-21 | — | — | EP | disclosed |
| CN-115135662-A | Iridium complex compound, composition containing iridium complex compound, organic electroluminescent element and method for producing same, organic EL display device, and organic EL lighting device | 三菱化学株式会社 | 2022-09-30 | — | — | CN | disclosed |
| WO-2022115039-A1 | MAGNETIC NANOCOMPOSITE MATERIALS SUITABLE FOR MAGNETIC LOCALIZED POLYMERISATION OF AN ANAEROBIC ADHESIVE | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2022-06-02 | — | — | WO | disclosed |
| WO-2022092046-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC EL DISPLAY DEVICE, AND ORGANIC EL LIGHTING | 三菱ケミカル株式会社 | 2022-05-05 | — | — | WO | disclosed |
| WO-2021161974-A1 | IRIDIUM COMPLEX COMPOUND, IRIDIUM COMPLEX COMPOUND-CONTAINING COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT AND PRODUCTION METHOD THEREFOR, ORGANIC EL DISPLAY DEVICE, AND ORGANIC EL LIGHTING DEVICE | 三菱ケミカル株式会社 | 2021-08-19 | — | — | WO | disclosed |
| US-8003645-B2 | type II diabetes; 6-Ethyl-N,N'-bis(3-hydroxyphenyl)-1,3,5-triazine-2,4-diamine; suppress the fall in MTT reduction capacity by beta -amyloid protein; inhibit impairment of long-term potentiation of hippocampal nerve cells, pyrimidine or 1,3,5 triazine derivatives | BTG INTERNATIONAL LTD. (GB) | 2011-08-23 | — | — | US | disclosed |
| US-20090286794-A1 | Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound | BTG INTERNATIONAL LTD. (GB) | 2009-11-19 | — | — | US | disclosed |
| US-20090286809-A1 | Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound | BTG INTERNATIONAL LTD. (GB) | 2009-11-19 | — | — | US | disclosed |
| US-7589105-B2 | For example, N,N'-bis(3-hydroxyphenyl)pyrimidine-4,6-diamine, 2-methyl-N,N'-bis(3-hydroxyphenyl)pyrimidine-4,6-diamine | BTG INTERNATIONAL LIMITED (GB) | 2009-09-15 | — | — | US | disclosed |
| EP-1473289-B1 | PREVENTIVES OR REMEDIES FOR ALZHEIMER'S DISEASE OR AMYLOID PROTEIN FIBROSIS INHIBITORS CONTAINING NITROGEN-CONTAINING HETEROARYL COMPOUNDS | BTG INT LTD (GB) | 2009-08-05 | — | — | EP | disclosed |
| US-20080182846-A1 | Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound | BTG INTERNATIONAL LIMITED (GB) | 2008-07-31 | — | — | US | disclosed |
| US-20050054732-A1 | Preventives or remidies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds | BTG INTERNATIONAL LTD. (GB) | 2005-03-10 | — | — | US | disclosed |
| EP-1473289-A1 | PREVENTIVES OR REMEDIES FOR ALZHEIMER'S DISEASE OR AMYLOID PROTEIN FIBROSIS INHIBITORS CONTAINING NITROGEN-CONTAINING HETEROARYL COMPOUNDS | Sankyo Company, Limited (JP) | 2004-11-03 | — | — | EP | disclosed |
| US-4659820-A | Process for the preparation of 4-alkoxy-6-alkyl-2-cyanamino-1,3,5-triazines | BAYER AKTIENGESELLSCHAFT (DE) | 1987-04-21 | — | — | US | disclosed |
| US-4211688-A | Process for dyeing high-molecular organic material in the melt | CIBA-GEIGY CORPORATION (US) | 1980-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054732-A1 | Preventives or remidies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds | NAT1, APP, BACE1 | ALDH1A1 1310/4885ALOX15 350/4885TSHR 3007/4885 |
| US-20230002428-A1 | Iridium Complex Compound, Iridium-Complex-Compound-Containing Composition, Organic Electroluminescent Element and Method for Producing Same, Organic EL Display Device, and Organic EL Illuminator | INF2, EMC2, DRD4 | ALDH1A1 989/4885ALOX15 1656/4885TSHR 1733/4885 |
| US-20260052903-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | EMC1, CRY1, CBR1 | ALDH1A1 174/4885ALOX15 1169/4885TSHR 1209/4885 |
| US-20090286794-A1 | Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound | APP, BACE1, PSEN1 | ALDH1A1 2328/4885ALOX15 447/4885TSHR 3082/4885 |
| US-11759528-B2 | Peg linker and ligand drug conjugate | EGFR, MPEG1, ERBB2 | ALDH1A1 1675/4885ALOX15 3964/4885TSHR 225/4885 |
| US-20090286809-A1 | Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound | APP, BACE1, PSEN1 | ALDH1A1 2328/4885ALOX15 447/4885TSHR 3082/4885 |
| US-20080182846-A1 | Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound | APP, BACE1, PSEN1 | ALDH1A1 2328/4885ALOX15 447/4885TSHR 3082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.